Pyrrolo[1,2-c]pyrimidine-3-carboxylic acid, 95.0%, 1g

2-(Trifluoromethyl)quinoline-4-carboxylic acid, 97.0%, 100mg

3-Allyloxyphenylboronic acid, 95.0%, 5g

2-Chloronicotinamide, 97.0%, 100g

1-(4-Chloro-benzyl)-1H-pyrazole-4-carboxylic acid ethyl ester, 95.0%, 1g

1-(2-Bromo-ethyl)-3-chloro-benzene, 97.0%, 5g

5-Amino-2-methyl-3,4-dihydroisoquinolin-1(2H)-one, 250mg

(3aS,3?aS,4S,4?S,6S,6?S,7aR,7?aR)-Dodecahydro-3a,3?a,5,5,5?,5?-hexamethyl-2,2?-bi-4,6-methano-1,3,2-benzodioxaborole, 98%, 100g

2-Acetyl-3-methylquinoxaline 1,4-dioxide, 95+%, 5g

2-[(1-bromonaphthalen-2-yl)oxy]-N'-hydroxyethanimidamide, 97%, 1g

Glass syringe with Luer connection (glass), 3 ml, 1 piece

5-Bromo-2-(4-methoxyphenyl)pyridine, 95+%, 1g

Ethylene glycol-O,O'-bis(2-aminoethyl)-N,N,N',N'-tetraacetic acid, 97.0%, 25g